VIE Equity Snapshot

GMAB Weekly Equity Report

Genmab A/S

Interactive chart JSON snapshot
Latest Close 215.5 EUR 12 Jun 2026
1W Return -0.2% latest completed week
4W Return -5.8% short-term follow-through
12W Return -1.4% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter's syndrome, and aggressive mature B-cell neoplasms in pediatric …

Snapshot

What the weekly tape is saying

GMAB closed the latest completed week at 215.5 EUR. The 4-week return is -5.8% and the 12-week return is -1.4%. Trend Signal is inactive, Market Dynamics is -0.28. Setup signature: Risk-first tape with a 23/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -13.6%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 28 Persistence of active Trend Signal over the last year and current streak.
Momentum 35 Blend of 4-week and 12-week follow-through.
Dynamics 51 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 23 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
249.5 EUR
Vs Trend Line
-13.6%
Fair Value
248.7 EUR
Vs Fair Value
-13.4%
52W High
302.4 EUR
52W Low
171.6 EUR
Drawdown
-28.7%
Range Position
33.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.2%
4W -5.8%
12W -1.4%
26W -20.0%
52W 8.2%

Trend read

Active Streak
0 weeks
52W Active Weeks
26
52W Active Breadth
50.0%
Sector Scope
AT Healthcare
Sector Rank
53 of 112
Sector Percentile
53.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.28
4W MD Change
75.7%
Relative Strength
-25.97
4W RS Change
-52.8%
Expectation
Undecided
Probability
48.42%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
0
52W Average
15
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.4%
52W Volatility
4.8%
Upside Weeks
27
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
3.8% / -3.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
13.8B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 215.5 EUR -0.2% 249.5 EUR 248.7 EUR -0.28 -25.97 0 Off
5 Jun 2026 216.0 EUR -5.1% 251.0 EUR 249.7 EUR -0.35 -24.02 0 Off
29 May 2026 227.5 EUR -1.2% 252.0 EUR 250.6 EUR -0.60 -21.09 0 Off
22 May 2026 230.3 EUR 0.7% 252.7 EUR 251.5 EUR -0.90 -18.06 0 Off
15 May 2026 228.8 EUR 4.0% 253.5 EUR 252.4 EUR -1.15 -17.00 4 Off
8 May 2026 220.0 EUR -2.7% 255.2 EUR 253.4 EUR -1.29 -20.54 0 Off
1 May 2026 226.1 EUR -1.4% 257.0 EUR 254.5 EUR -1.20 -17.21 0 Off
24 Apr 2026 229.3 EUR -5.8% 258.9 EUR 255.4 EUR -1.21 -15.68 0 Off
17 Apr 2026 243.5 EUR 1.4% 259.4 EUR 256.3 EUR -1.26 -13.69 0 Off
10 Apr 2026 240.2 EUR 4.3% 259.4 EUR 257.1 EUR -1.36 -12.87 0 Off
3 Apr 2026 230.4 EUR 2.4% 259.4 EUR 258.0 EUR -1.48 -11.07 0 Off
27 Mar 2026 224.9 EUR 2.9% 259.6 EUR 258.8 EUR -1.52 -10.22 0 Off
20 Mar 2026 218.6 EUR -5.7% 259.2 EUR 259.6 EUR -1.52 -11.49 0 Off
13 Mar 2026 231.9 EUR 0.1% 259.0 EUR 260.4 EUR -1.51 -7.37 0 Off